Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Genetic Technologies Ltd. (GENE)

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/10/2002

Market Cap

6,463,794

Shares Outstanding

115,420,000

Weighted SO

3,847,219

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BIOC --.--%

TTOO --.--%

HTGM --.--%

INBS --.--%

IDXG --.--%

BIAF --.--%

SQL --.--%

A --.--%

Beta

0.4440

Last Div

0.0000

Range

0.69-4.65

Chg

-0.0215

Avg Vol

80711

Mkt Cap

6463794

Exch

NASDAQ

Country

AU

Phone

61 3 8412 7000

DCF Diff

1.6803

DCF

2.6078

Div Yield

0.0000

P/S

0.7123

EV Multiple

-0.4520

P/FV

30.1250

Div Yield %

0.0000

P/E

-7.6038

PEG

-0.1826

Payout

0.0000

Current Ratio

1.6704

Quick Ratio

1.5545

Cash Ratio

1.0898

DSO

29.9095

DIO

10.5943

Op Cycle

40.5037

DPO

51.1865

CCC

-10.6827

Gross Margin

-0.0040

Op Margin

-1.0902

Pretax Margin

-1.4017

Net Margin

-1.4006

Eff Tax Rate

0.0003

ROA

-2.2517

ROE

-2.3869

ROCE

-2.9415

NI/EBT

0.9992

EBT/EBIT

1.2857

EBIT/Rev

-1.0902

Debt Ratio

0.0452

D/E

0.0794

LT Debt/Cap

0.0172

Total Debt/Cap

0.0736

Int Coverage

-560.0930

CF/Debt

-22.2930

Equity Multi

1.7595

Rec Turnover

12.2035

Pay Turnover

7.1308

Inv Turnover

34.4526

FA Turnover

31.7135

Asset Turnover

1.6077

OCF/Share

-0.0706

FCF/Share

-0.0709

Cash/Share

0.0309

OCF/Sales

-0.6261

FCF/OCF

1.0048

CF Coverage

-22.2930

ST Coverage

-28.5833

CapEx Coverage

-207.8783

Div&CapEx Cov

-207.8783

P/BV

30.1250

P/B

30.1250

P/S

0.7123

P/E

-7.6038

P/FCF

-1.1322

P/OCF

-17.0087

P/CF

-17.0087

PEG

-0.1826

P/S

0.7123

EV Multiple

-0.4520

P/FV

30.1250

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation